Skip to main content

DNA

Stock

DNA

Stock
Health Care
Biotechnology

Performance overview

DNA Price
Price Chart

Forward-looking statistics

Beta
1.20
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

the organism company ginkgo bioworks engineers new organisms to solve challenges across a range of industries from fuels to pharmaceutical production. our biological engineers make use of an in-house pipeline of synthetic biology technologies to design, build, and test new organisms.

Company info

SectorHealth Care
IndustryBiotechnology
Employees1K
Market cap$1.1B

Fundamentals

Enterprise value$576.1M
Revenue$237.4M
Revenue per employee—
Profit margin-198.84%
Debt to equity67.12

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)-$8.91
Dividend per share—
Revenue per share$4.49
Avg trading volume (30 day)$14M
Avg trading volume (10 day)$21M
Put-call ratio—

Macro factor sensitivity

Growth+0.8
Credit+9.3
Liquidity-3.5
Inflation-5.7
Commodities+2.1
Interest Rates-2.8

Valuation

Dividend yield0.00%
PEG Ratio-1.60
Price to sales3.14
P/E Ratio-1.60
Enterprise Value to Revenue2.43
Price to book1.07

Upcoming events

Next earnings dayMay 10, 2024
Next dividend day—
Ex. dividend day—

News

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why

In the closing of the recent trading day, Ginkgo Bioworks Holdings, Inc. (DNA) stood at $10.79, denoting a -2.53% move from the preceding trading day.

Zacks Investment Research (July 10, 2025)
Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Wednesday.

Benzinga (February 26, 2025)
Ginkgo Bioworks CEO: Our AI model will learn to speak DNA just like ChatGPT learned English

Jason Kelly, Ginkgo Bioworks CEO, joins 'Closing Bell Overtime' to talk partnering with Google Cloud, its AI offerings and more.

CNBC Television (September 1, 2023)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free